nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00116	0.0021	CcSEcCtD
Dasatinib—Confusional state—Etidronic acid—Paget's disease of bone	0.00115	0.00208	CcSEcCtD
Dasatinib—Muscle spasms—Alendronate—Paget's disease of bone	0.00115	0.00208	CcSEcCtD
Dasatinib—Renal failure—Pamidronate—Paget's disease of bone	0.00115	0.00207	CcSEcCtD
Dasatinib—Infection—Etidronic acid—Paget's disease of bone	0.00114	0.00205	CcSEcCtD
Dasatinib—Stomatitis—Pamidronate—Paget's disease of bone	0.00114	0.00205	CcSEcCtD
Dasatinib—Pancytopenia—Zoledronate—Paget's disease of bone	0.00114	0.00205	CcSEcCtD
Dasatinib—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00113	0.00205	CcSEcCtD
Dasatinib—Neutropenia—Zoledronate—Paget's disease of bone	0.00112	0.00202	CcSEcCtD
Dasatinib—Haematuria—Pamidronate—Paget's disease of bone	0.00111	0.00201	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00111	0.00201	CcSEcCtD
Dasatinib—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00111	0.002	CcSEcCtD
Dasatinib—Haemoglobin—Risedronate—Paget's disease of bone	0.00111	0.002	CcSEcCtD
Dasatinib—Anaemia—Alendronate—Paget's disease of bone	0.0011	0.002	CcSEcCtD
Dasatinib—Pollakiuria—Zoledronate—Paget's disease of bone	0.0011	0.00199	CcSEcCtD
Dasatinib—Haemorrhage—Risedronate—Paget's disease of bone	0.0011	0.00199	CcSEcCtD
Dasatinib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00109	0.00197	CcSEcCtD
Dasatinib—Weight increased—Zoledronate—Paget's disease of bone	0.00109	0.00196	CcSEcCtD
Dasatinib—Oedema peripheral—Risedronate—Paget's disease of bone	0.00109	0.00196	CcSEcCtD
Dasatinib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00108	0.00196	CcSEcCtD
Dasatinib—Weight decreased—Zoledronate—Paget's disease of bone	0.00108	0.00195	CcSEcCtD
Dasatinib—Urethral disorder—Risedronate—Paget's disease of bone	0.00108	0.00195	CcSEcCtD
Dasatinib—Malaise—Alendronate—Paget's disease of bone	0.00108	0.00195	CcSEcCtD
Dasatinib—Vertigo—Alendronate—Paget's disease of bone	0.00107	0.00194	CcSEcCtD
Dasatinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00107	0.00192	CcSEcCtD
Dasatinib—Infestation—Zoledronate—Paget's disease of bone	0.00107	0.00192	CcSEcCtD
Dasatinib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00105	0.0019	CcSEcCtD
Dasatinib—Renal failure—Zoledronate—Paget's disease of bone	0.00105	0.00189	CcSEcCtD
Dasatinib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00105	0.00189	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00104	0.00188	CcSEcCtD
Dasatinib—Stomatitis—Zoledronate—Paget's disease of bone	0.00104	0.00188	CcSEcCtD
Dasatinib—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00104	0.00187	CcSEcCtD
Dasatinib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00103	0.00187	CcSEcCtD
Dasatinib—Eye disorder—Risedronate—Paget's disease of bone	0.00103	0.00186	CcSEcCtD
Dasatinib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00103	0.00186	CcSEcCtD
Dasatinib—Tinnitus—Risedronate—Paget's disease of bone	0.00103	0.00186	CcSEcCtD
Dasatinib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00103	0.00185	CcSEcCtD
Dasatinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00102	0.00185	CcSEcCtD
Dasatinib—Chest pain—Alendronate—Paget's disease of bone	0.00102	0.00184	CcSEcCtD
Dasatinib—Myalgia—Alendronate—Paget's disease of bone	0.00102	0.00184	CcSEcCtD
Dasatinib—Haematuria—Zoledronate—Paget's disease of bone	0.00102	0.00184	CcSEcCtD
Dasatinib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00101	0.00182	CcSEcCtD
Dasatinib—Discomfort—Alendronate—Paget's disease of bone	0.00101	0.00182	CcSEcCtD
Dasatinib—Angiopathy—Risedronate—Paget's disease of bone	0.001	0.00181	CcSEcCtD
Dasatinib—Immune system disorder—Risedronate—Paget's disease of bone	0.000995	0.0018	CcSEcCtD
Dasatinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.000993	0.00179	CcSEcCtD
Dasatinib—Arrhythmia—Risedronate—Paget's disease of bone	0.000984	0.00178	CcSEcCtD
Dasatinib—Constipation—Etidronic acid—Paget's disease of bone	0.000979	0.00177	CcSEcCtD
Dasatinib—Eye disorder—Pamidronate—Paget's disease of bone	0.000979	0.00177	CcSEcCtD
Dasatinib—Flushing—Pamidronate—Paget's disease of bone	0.000972	0.00176	CcSEcCtD
Dasatinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000972	0.00176	CcSEcCtD
Dasatinib—Infection—Alendronate—Paget's disease of bone	0.000969	0.00175	CcSEcCtD
Dasatinib—Mental disorder—Risedronate—Paget's disease of bone	0.000965	0.00174	CcSEcCtD
Dasatinib—Malnutrition—Risedronate—Paget's disease of bone	0.000959	0.00173	CcSEcCtD
Dasatinib—Angiopathy—Pamidronate—Paget's disease of bone	0.00095	0.00172	CcSEcCtD
Dasatinib—Immune system disorder—Pamidronate—Paget's disease of bone	0.000946	0.00171	CcSEcCtD
Dasatinib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000945	0.00171	CcSEcCtD
Dasatinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000944	0.0017	CcSEcCtD
Dasatinib—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000944	0.0017	CcSEcCtD
Dasatinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000943	0.0017	CcSEcCtD
Dasatinib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00094	0.0017	CcSEcCtD
Dasatinib—Chills—Pamidronate—Paget's disease of bone	0.00094	0.0017	CcSEcCtD
Dasatinib—Urethral disorder—Zoledronate—Paget's disease of bone	0.000938	0.00169	CcSEcCtD
Dasatinib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.000936	0.00169	CcSEcCtD
Dasatinib—Alopecia—Pamidronate—Paget's disease of bone	0.000926	0.00167	CcSEcCtD
Dasatinib—Muscle spasms—Risedronate—Paget's disease of bone	0.000922	0.00167	CcSEcCtD
Dasatinib—Malnutrition—Pamidronate—Paget's disease of bone	0.000912	0.00165	CcSEcCtD
Dasatinib—Erythema—Pamidronate—Paget's disease of bone	0.000912	0.00165	CcSEcCtD
Dasatinib—Urticaria—Etidronic acid—Paget's disease of bone	0.00091	0.00164	CcSEcCtD
Dasatinib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000905	0.00163	CcSEcCtD
Dasatinib—Eye disorder—Zoledronate—Paget's disease of bone	0.000894	0.00161	CcSEcCtD
Dasatinib—Dysgeusia—Pamidronate—Paget's disease of bone	0.000893	0.00161	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000889	0.00161	CcSEcCtD
Dasatinib—Flushing—Zoledronate—Paget's disease of bone	0.000888	0.0016	CcSEcCtD
Dasatinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000888	0.0016	CcSEcCtD
Dasatinib—Anaemia—Risedronate—Paget's disease of bone	0.000887	0.0016	CcSEcCtD
Dasatinib—Muscle spasms—Pamidronate—Paget's disease of bone	0.000877	0.00158	CcSEcCtD
Dasatinib—Angiopathy—Zoledronate—Paget's disease of bone	0.000868	0.00157	CcSEcCtD
Dasatinib—Immune system disorder—Zoledronate—Paget's disease of bone	0.000864	0.00156	CcSEcCtD
Dasatinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000862	0.00156	CcSEcCtD
Dasatinib—Vertigo—Risedronate—Paget's disease of bone	0.000862	0.00156	CcSEcCtD
Dasatinib—Syncope—Risedronate—Paget's disease of bone	0.00086	0.00155	CcSEcCtD
Dasatinib—Dyspepsia—Alendronate—Paget's disease of bone	0.000859	0.00155	CcSEcCtD
Dasatinib—Chills—Zoledronate—Paget's disease of bone	0.000858	0.00155	CcSEcCtD
Dasatinib—Arrhythmia—Zoledronate—Paget's disease of bone	0.000855	0.00154	CcSEcCtD
Dasatinib—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000846	0.00153	CcSEcCtD
Dasatinib—Alopecia—Zoledronate—Paget's disease of bone	0.000845	0.00153	CcSEcCtD
Dasatinib—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000844	0.00152	CcSEcCtD
Dasatinib—Loss of consciousness—Risedronate—Paget's disease of bone	0.000843	0.00152	CcSEcCtD
Dasatinib—Anaemia—Pamidronate—Paget's disease of bone	0.000843	0.00152	CcSEcCtD
Dasatinib—Mental disorder—Zoledronate—Paget's disease of bone	0.000838	0.00151	CcSEcCtD
Dasatinib—Cough—Risedronate—Paget's disease of bone	0.000837	0.00151	CcSEcCtD
Dasatinib—Constipation—Alendronate—Paget's disease of bone	0.000834	0.00151	CcSEcCtD
Dasatinib—Pain—Alendronate—Paget's disease of bone	0.000834	0.00151	CcSEcCtD
Dasatinib—Erythema—Zoledronate—Paget's disease of bone	0.000833	0.0015	CcSEcCtD
Dasatinib—Malnutrition—Zoledronate—Paget's disease of bone	0.000833	0.0015	CcSEcCtD
Dasatinib—Hypertension—Risedronate—Paget's disease of bone	0.000828	0.0015	CcSEcCtD
Dasatinib—Malaise—Pamidronate—Paget's disease of bone	0.000822	0.00148	CcSEcCtD
Dasatinib—Syncope—Pamidronate—Paget's disease of bone	0.000818	0.00148	CcSEcCtD
Dasatinib—Myalgia—Risedronate—Paget's disease of bone	0.000817	0.00147	CcSEcCtD
Dasatinib—Arthralgia—Risedronate—Paget's disease of bone	0.000817	0.00147	CcSEcCtD
Dasatinib—Chest pain—Risedronate—Paget's disease of bone	0.000817	0.00147	CcSEcCtD
Dasatinib—Dysgeusia—Zoledronate—Paget's disease of bone	0.000816	0.00147	CcSEcCtD
Dasatinib—Anxiety—Risedronate—Paget's disease of bone	0.000814	0.00147	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.000811	0.00146	CcSEcCtD
Dasatinib—Pruritus—Etidronic acid—Paget's disease of bone	0.00081	0.00146	CcSEcCtD
Dasatinib—Feeling abnormal—Alendronate—Paget's disease of bone	0.000804	0.00145	CcSEcCtD
Dasatinib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000801	0.00145	CcSEcCtD
Dasatinib—Muscle spasms—Zoledronate—Paget's disease of bone	0.000801	0.00145	CcSEcCtD
Dasatinib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000798	0.00144	CcSEcCtD
Dasatinib—Cough—Pamidronate—Paget's disease of bone	0.000796	0.00144	CcSEcCtD
Dasatinib—Convulsion—Pamidronate—Paget's disease of bone	0.00079	0.00143	CcSEcCtD
Dasatinib—Hypertension—Pamidronate—Paget's disease of bone	0.000787	0.00142	CcSEcCtD
Dasatinib—Vision blurred—Zoledronate—Paget's disease of bone	0.000785	0.00142	CcSEcCtD
Dasatinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000783	0.00141	CcSEcCtD
Dasatinib—Tremor—Zoledronate—Paget's disease of bone	0.00078	0.00141	CcSEcCtD
Dasatinib—Infection—Risedronate—Paget's disease of bone	0.000778	0.0014	CcSEcCtD
Dasatinib—Arthralgia—Pamidronate—Paget's disease of bone	0.000776	0.0014	CcSEcCtD
Dasatinib—Myalgia—Pamidronate—Paget's disease of bone	0.000776	0.0014	CcSEcCtD
Dasatinib—Urticaria—Alendronate—Paget's disease of bone	0.000775	0.0014	CcSEcCtD
Dasatinib—Anxiety—Pamidronate—Paget's disease of bone	0.000774	0.0014	CcSEcCtD
Dasatinib—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000773	0.0014	CcSEcCtD
Dasatinib—Abdominal pain—Alendronate—Paget's disease of bone	0.000771	0.00139	CcSEcCtD
Dasatinib—Body temperature increased—Alendronate—Paget's disease of bone	0.000771	0.00139	CcSEcCtD
Dasatinib—Shock—Risedronate—Paget's disease of bone	0.00077	0.00139	CcSEcCtD
Dasatinib—Anaemia—Zoledronate—Paget's disease of bone	0.00077	0.00139	CcSEcCtD
Dasatinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.000768	0.00139	CcSEcCtD
Dasatinib—Discomfort—Pamidronate—Paget's disease of bone	0.000767	0.00139	CcSEcCtD
Dasatinib—Skin disorder—Risedronate—Paget's disease of bone	0.00076	0.00137	CcSEcCtD
Dasatinib—Malaise—Zoledronate—Paget's disease of bone	0.000751	0.00136	CcSEcCtD
Dasatinib—Confusional state—Pamidronate—Paget's disease of bone	0.00075	0.00136	CcSEcCtD
Dasatinib—Vertigo—Zoledronate—Paget's disease of bone	0.000748	0.00135	CcSEcCtD
Dasatinib—Syncope—Zoledronate—Paget's disease of bone	0.000747	0.00135	CcSEcCtD
Dasatinib—Oedema—Pamidronate—Paget's disease of bone	0.000744	0.00134	CcSEcCtD
Dasatinib—Infection—Pamidronate—Paget's disease of bone	0.000739	0.00134	CcSEcCtD
Dasatinib—Palpitations—Zoledronate—Paget's disease of bone	0.000736	0.00133	CcSEcCtD
Dasatinib—Shock—Pamidronate—Paget's disease of bone	0.000732	0.00132	CcSEcCtD
Dasatinib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000732	0.00132	CcSEcCtD
Dasatinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00073	0.00132	CcSEcCtD
Dasatinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000729	0.00132	CcSEcCtD
Dasatinib—Vomiting—Etidronic acid—Paget's disease of bone	0.000728	0.00131	CcSEcCtD
Dasatinib—Cough—Zoledronate—Paget's disease of bone	0.000727	0.00131	CcSEcCtD
Dasatinib—Tachycardia—Pamidronate—Paget's disease of bone	0.000726	0.00131	CcSEcCtD
Dasatinib—Rash—Etidronic acid—Paget's disease of bone	0.000722	0.0013	CcSEcCtD
Dasatinib—Convulsion—Zoledronate—Paget's disease of bone	0.000722	0.0013	CcSEcCtD
Dasatinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.000721	0.0013	CcSEcCtD
Dasatinib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000719	0.0013	CcSEcCtD
Dasatinib—Hypertension—Zoledronate—Paget's disease of bone	0.000719	0.0013	CcSEcCtD
Dasatinib—Hypersensitivity—Alendronate—Paget's disease of bone	0.000719	0.0013	CcSEcCtD
Dasatinib—Headache—Etidronic acid—Paget's disease of bone	0.000717	0.0013	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000713	0.00129	CcSEcCtD
Dasatinib—Anorexia—Pamidronate—Paget's disease of bone	0.000709	0.00128	CcSEcCtD
Dasatinib—Arthralgia—Zoledronate—Paget's disease of bone	0.000709	0.00128	CcSEcCtD
Dasatinib—Chest pain—Zoledronate—Paget's disease of bone	0.000709	0.00128	CcSEcCtD
Dasatinib—Myalgia—Zoledronate—Paget's disease of bone	0.000709	0.00128	CcSEcCtD
Dasatinib—Insomnia—Risedronate—Paget's disease of bone	0.000708	0.00128	CcSEcCtD
Dasatinib—Anxiety—Zoledronate—Paget's disease of bone	0.000707	0.00128	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000704	0.00127	CcSEcCtD
Dasatinib—Discomfort—Zoledronate—Paget's disease of bone	0.000701	0.00127	CcSEcCtD
Dasatinib—Asthenia—Alendronate—Paget's disease of bone	0.0007	0.00126	CcSEcCtD
Dasatinib—Dyspnoea—Risedronate—Paget's disease of bone	0.000698	0.00126	CcSEcCtD
Dasatinib—Hypotension—Pamidronate—Paget's disease of bone	0.000695	0.00126	CcSEcCtD
Dasatinib—Pruritus—Alendronate—Paget's disease of bone	0.00069	0.00125	CcSEcCtD
Dasatinib—Dyspepsia—Risedronate—Paget's disease of bone	0.000689	0.00124	CcSEcCtD
Dasatinib—Confusional state—Zoledronate—Paget's disease of bone	0.000685	0.00124	CcSEcCtD
Dasatinib—Nausea—Etidronic acid—Paget's disease of bone	0.00068	0.00123	CcSEcCtD
Dasatinib—Oedema—Zoledronate—Paget's disease of bone	0.00068	0.00123	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000678	0.00122	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000676	0.00122	CcSEcCtD
Dasatinib—Infection—Zoledronate—Paget's disease of bone	0.000675	0.00122	CcSEcCtD
Dasatinib—Fatigue—Risedronate—Paget's disease of bone	0.000675	0.00122	CcSEcCtD
Dasatinib—Insomnia—Pamidronate—Paget's disease of bone	0.000673	0.00122	CcSEcCtD
Dasatinib—Pain—Risedronate—Paget's disease of bone	0.000669	0.00121	CcSEcCtD
Dasatinib—Constipation—Risedronate—Paget's disease of bone	0.000669	0.00121	CcSEcCtD
Dasatinib—Shock—Zoledronate—Paget's disease of bone	0.000669	0.00121	CcSEcCtD
Dasatinib—Diarrhoea—Alendronate—Paget's disease of bone	0.000668	0.00121	CcSEcCtD
Dasatinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000667	0.0012	CcSEcCtD
Dasatinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000666	0.0012	CcSEcCtD
Dasatinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.000663	0.0012	CcSEcCtD
Dasatinib—Tachycardia—Zoledronate—Paget's disease of bone	0.000663	0.0012	CcSEcCtD
Dasatinib—Somnolence—Pamidronate—Paget's disease of bone	0.000662	0.00119	CcSEcCtD
Dasatinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00066	0.00119	CcSEcCtD
Dasatinib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000657	0.00119	CcSEcCtD
Dasatinib—Dyspepsia—Pamidronate—Paget's disease of bone	0.000655	0.00118	CcSEcCtD
Dasatinib—Anorexia—Zoledronate—Paget's disease of bone	0.000648	0.00117	CcSEcCtD
Dasatinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.000647	0.00117	CcSEcCtD
Dasatinib—Dizziness—Alendronate—Paget's disease of bone	0.000645	0.00117	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000642	0.00116	CcSEcCtD
Dasatinib—Fatigue—Pamidronate—Paget's disease of bone	0.000642	0.00116	CcSEcCtD
Dasatinib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00064	0.00116	CcSEcCtD
Dasatinib—Pain—Pamidronate—Paget's disease of bone	0.000636	0.00115	CcSEcCtD
Dasatinib—Constipation—Pamidronate—Paget's disease of bone	0.000636	0.00115	CcSEcCtD
Dasatinib—Hypotension—Zoledronate—Paget's disease of bone	0.000635	0.00115	CcSEcCtD
Dasatinib—Urticaria—Risedronate—Paget's disease of bone	0.000622	0.00112	CcSEcCtD
Dasatinib—Vomiting—Alendronate—Paget's disease of bone	0.00062	0.00112	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000619	0.00112	CcSEcCtD
Dasatinib—Abdominal pain—Risedronate—Paget's disease of bone	0.000619	0.00112	CcSEcCtD
Dasatinib—Body temperature increased—Risedronate—Paget's disease of bone	0.000619	0.00112	CcSEcCtD
Dasatinib—Rash—Alendronate—Paget's disease of bone	0.000615	0.00111	CcSEcCtD
Dasatinib—Insomnia—Zoledronate—Paget's disease of bone	0.000615	0.00111	CcSEcCtD
Dasatinib—Dermatitis—Alendronate—Paget's disease of bone	0.000615	0.00111	CcSEcCtD
Dasatinib—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000613	0.00111	CcSEcCtD
Dasatinib—Headache—Alendronate—Paget's disease of bone	0.000611	0.0011	CcSEcCtD
Dasatinib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000609	0.0011	CcSEcCtD
Dasatinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000606	0.00109	CcSEcCtD
Dasatinib—Somnolence—Zoledronate—Paget's disease of bone	0.000604	0.00109	CcSEcCtD
Dasatinib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000598	0.00108	CcSEcCtD
Dasatinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000591	0.00107	CcSEcCtD
Dasatinib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000588	0.00106	CcSEcCtD
Dasatinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000588	0.00106	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000587	0.00106	CcSEcCtD
Dasatinib—Fatigue—Zoledronate—Paget's disease of bone	0.000586	0.00106	CcSEcCtD
Dasatinib—Pain—Zoledronate—Paget's disease of bone	0.000581	0.00105	CcSEcCtD
Dasatinib—Constipation—Zoledronate—Paget's disease of bone	0.000581	0.00105	CcSEcCtD
Dasatinib—Nausea—Alendronate—Paget's disease of bone	0.00058	0.00105	CcSEcCtD
Dasatinib—Hypersensitivity—Risedronate—Paget's disease of bone	0.000577	0.00104	CcSEcCtD
Dasatinib—Asthenia—Risedronate—Paget's disease of bone	0.000562	0.00101	CcSEcCtD
Dasatinib—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00056	0.00101	CcSEcCtD
Dasatinib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000556	0.001	CcSEcCtD
Dasatinib—Pruritus—Risedronate—Paget's disease of bone	0.000554	0.001	CcSEcCtD
Dasatinib—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000548	0.00099	CcSEcCtD
Dasatinib—Urticaria—Zoledronate—Paget's disease of bone	0.00054	0.000975	CcSEcCtD
Dasatinib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000537	0.00097	CcSEcCtD
Dasatinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000537	0.00097	CcSEcCtD
Dasatinib—Diarrhoea—Risedronate—Paget's disease of bone	0.000536	0.000967	CcSEcCtD
Dasatinib—Asthenia—Pamidronate—Paget's disease of bone	0.000534	0.000964	CcSEcCtD
Dasatinib—Pruritus—Pamidronate—Paget's disease of bone	0.000527	0.000951	CcSEcCtD
Dasatinib—Dizziness—Risedronate—Paget's disease of bone	0.000518	0.000935	CcSEcCtD
Dasatinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000509	0.00092	CcSEcCtD
Dasatinib—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000501	0.000904	CcSEcCtD
Dasatinib—Vomiting—Risedronate—Paget's disease of bone	0.000498	0.000899	CcSEcCtD
Dasatinib—Rash—Risedronate—Paget's disease of bone	0.000494	0.000891	CcSEcCtD
Dasatinib—Dermatitis—Risedronate—Paget's disease of bone	0.000493	0.000891	CcSEcCtD
Dasatinib—Dizziness—Pamidronate—Paget's disease of bone	0.000492	0.000889	CcSEcCtD
Dasatinib—Headache—Risedronate—Paget's disease of bone	0.00049	0.000886	CcSEcCtD
Dasatinib—Asthenia—Zoledronate—Paget's disease of bone	0.000488	0.000881	CcSEcCtD
Dasatinib—Pruritus—Zoledronate—Paget's disease of bone	0.000481	0.000869	CcSEcCtD
Dasatinib—Vomiting—Pamidronate—Paget's disease of bone	0.000473	0.000854	CcSEcCtD
Dasatinib—Rash—Pamidronate—Paget's disease of bone	0.000469	0.000847	CcSEcCtD
Dasatinib—Dermatitis—Pamidronate—Paget's disease of bone	0.000469	0.000847	CcSEcCtD
Dasatinib—Headache—Pamidronate—Paget's disease of bone	0.000466	0.000842	CcSEcCtD
Dasatinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000465	0.00084	CcSEcCtD
Dasatinib—Nausea—Risedronate—Paget's disease of bone	0.000465	0.00084	CcSEcCtD
Dasatinib—Dizziness—Zoledronate—Paget's disease of bone	0.00045	0.000812	CcSEcCtD
Dasatinib—Nausea—Pamidronate—Paget's disease of bone	0.000442	0.000798	CcSEcCtD
Dasatinib—Vomiting—Zoledronate—Paget's disease of bone	0.000432	0.000781	CcSEcCtD
Dasatinib—Rash—Zoledronate—Paget's disease of bone	0.000429	0.000774	CcSEcCtD
Dasatinib—Dermatitis—Zoledronate—Paget's disease of bone	0.000428	0.000773	CcSEcCtD
Dasatinib—Headache—Zoledronate—Paget's disease of bone	0.000426	0.000769	CcSEcCtD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00042	0.000941	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000419	0.000938	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000417	0.000934	CbGpPWpGaD
Dasatinib—YES1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000417	0.000933	CbGpPWpGaD
Dasatinib—SRC—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000411	0.000922	CbGpPWpGaD
Dasatinib—Nausea—Zoledronate—Paget's disease of bone	0.000404	0.000729	CcSEcCtD
Dasatinib—ERBB3—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000404	0.000904	CbGpPWpGaD
Dasatinib—YES1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000402	0.000901	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.0004	0.000896	CbGpPWpGaD
Dasatinib—SRMS—Immune System—SQSTM1—Paget's disease of bone	0.000394	0.000883	CbGpPWpGaD
Dasatinib—TXK—Immune System—PML—Paget's disease of bone	0.000387	0.000868	CbGpPWpGaD
Dasatinib—CSK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000387	0.000867	CbGpPWpGaD
Dasatinib—TXK—Immune System—INPP5D—Paget's disease of bone	0.000374	0.000837	CbGpPWpGaD
Dasatinib—YES1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.00036	0.000807	CbGpPWpGaD
Dasatinib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.000355	0.000794	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000351	0.000788	CbGpPWpGaD
Dasatinib—MAPK14—Metabolism of RNA—NUP205—Paget's disease of bone	0.000347	0.000778	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000346	0.000775	CbGpPWpGaD
Dasatinib—SRC—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000337	0.000755	CbGpPWpGaD
Dasatinib—TXK—Immune System—SQSTM1—Paget's disease of bone	0.000335	0.00075	CbGpPWpGaD
Dasatinib—CSK—Disease—VCP—Paget's disease of bone	0.000332	0.000745	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000332	0.000744	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—VCP—Paget's disease of bone	0.00033	0.00074	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000329	0.000737	CbGpPWpGaD
Dasatinib—BTK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000324	0.000725	CbGpPWpGaD
Dasatinib—STAT5B—Disease—VCP—Paget's disease of bone	0.000322	0.000721	CbGpPWpGaD
Dasatinib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000316	0.000709	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000311	0.000696	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—INPP5D—Paget's disease of bone	0.00031	0.000695	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000306	0.000686	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000306	0.000685	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.0003	0.000672	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000299	0.000671	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000295	0.000661	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000291	0.000651	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000288	0.000645	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.00028	0.000628	CbGpPWpGaD
Dasatinib—RIPK2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.00028	0.000627	CbGpPWpGaD
Dasatinib—CSK—Immune System—NUP205—Paget's disease of bone	0.000275	0.000617	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00027	0.000605	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000269	0.000603	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000269	0.000602	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—NUP205—Paget's disease of bone	0.000266	0.000597	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000264	0.000593	CbGpPWpGaD
Dasatinib—FYN—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00026	0.000583	CbGpPWpGaD
Dasatinib—HCK—Disease—VCP—Paget's disease of bone	0.000255	0.000572	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000255	0.00057	CbGpPWpGaD
Dasatinib—CSK—Disease—NUP205—Paget's disease of bone	0.000254	0.000569	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000251	0.000563	CbGpPWpGaD
Dasatinib—MAPK14—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00025	0.000561	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—INPP5D—Paget's disease of bone	0.00025	0.000561	CbGpPWpGaD
Dasatinib—JAK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000247	0.000554	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000247	0.000552	CbGpPWpGaD
Dasatinib—STAT5B—Disease—NUP205—Paget's disease of bone	0.000246	0.000551	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000246	0.00055	CbGpPWpGaD
Dasatinib—CSK—Immune System—PML—Paget's disease of bone	0.000243	0.000545	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—NUP205—Paget's disease of bone	0.000237	0.00053	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—PML—Paget's disease of bone	0.000236	0.000528	CbGpPWpGaD
Dasatinib—CSK—Immune System—INPP5D—Paget's disease of bone	0.000235	0.000526	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—VCP—Paget's disease of bone	0.000233	0.000522	CbGpPWpGaD
Dasatinib—BTK—Immune System—NUP205—Paget's disease of bone	0.00023	0.000516	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—INPP5D—Paget's disease of bone	0.000227	0.000509	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—VCP—Paget's disease of bone	0.000225	0.000505	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.00022	0.000493	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000216	0.000485	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000216	0.000485	CbGpPWpGaD
Dasatinib—ERBB3—Disease—VCP—Paget's disease of bone	0.000212	0.000475	CbGpPWpGaD
Dasatinib—HCK—Immune System—NUP205—Paget's disease of bone	0.000211	0.000473	CbGpPWpGaD
Dasatinib—CSK—Immune System—SQSTM1—Paget's disease of bone	0.00021	0.000471	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—PML—Paget's disease of bone	0.000209	0.000469	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—SQSTM1—Paget's disease of bone	0.000204	0.000456	CbGpPWpGaD
Dasatinib—BTK—Immune System—PML—Paget's disease of bone	0.000203	0.000456	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—INPP5D—Paget's disease of bone	0.000202	0.000452	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—NUP205—Paget's disease of bone	0.000199	0.000446	CbGpPWpGaD
Dasatinib—BTK—Immune System—INPP5D—Paget's disease of bone	0.000196	0.00044	CbGpPWpGaD
Dasatinib—HCK—Disease—NUP205—Paget's disease of bone	0.000195	0.000437	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000193	0.000433	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000193	0.000432	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000192	0.000429	CbGpPWpGaD
Dasatinib—BLK—Immune System—NUP205—Paget's disease of bone	0.000191	0.000429	CbGpPWpGaD
Dasatinib—FGR—Immune System—NUP205—Paget's disease of bone	0.000191	0.000427	CbGpPWpGaD
Dasatinib—CSK—Disease—CALCA—Paget's disease of bone	0.000189	0.000423	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000187	0.00042	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000187	0.000418	CbGpPWpGaD
Dasatinib—HCK—Immune System—PML—Paget's disease of bone	0.000187	0.000418	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.000186	0.000416	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—INPP5D—Paget's disease of bone	0.000184	0.000412	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000183	0.00041	CbGpPWpGaD
Dasatinib—STAT5B—Disease—CALCA—Paget's disease of bone	0.000183	0.000409	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000181	0.000406	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—SQSTM1—Paget's disease of bone	0.000181	0.000405	CbGpPWpGaD
Dasatinib—HCK—Immune System—INPP5D—Paget's disease of bone	0.00018	0.000404	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—INPP5D—Paget's disease of bone	0.000177	0.000397	CbGpPWpGaD
Dasatinib—BTK—Immune System—SQSTM1—Paget's disease of bone	0.000176	0.000394	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—PML—Paget's disease of bone	0.000176	0.000394	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—NUP205—Paget's disease of bone	0.000175	0.000393	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—INPP5D—Paget's disease of bone	0.000175	0.000391	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—NUP205—Paget's disease of bone	0.000173	0.000387	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—INPP5D—Paget's disease of bone	0.00017	0.00038	CbGpPWpGaD
Dasatinib—BLK—Immune System—PML—Paget's disease of bone	0.000169	0.000379	CbGpPWpGaD
Dasatinib—FGR—Immune System—PML—Paget's disease of bone	0.000169	0.000378	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—VCP—Paget's disease of bone	0.000168	0.000377	CbGpPWpGaD
Dasatinib—KIT—Disease—VCP—Paget's disease of bone	0.000166	0.000372	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000165	0.000369	CbGpPWpGaD
Dasatinib—BLK—Immune System—INPP5D—Paget's disease of bone	0.000163	0.000366	CbGpPWpGaD
Dasatinib—FGR—Immune System—INPP5D—Paget's disease of bone	0.000163	0.000364	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NUP205—Paget's disease of bone	0.000162	0.000363	CbGpPWpGaD
Dasatinib—HCK—Immune System—SQSTM1—Paget's disease of bone	0.000161	0.000362	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000161	0.000362	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000159	0.000356	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—VCP—Paget's disease of bone	0.000157	0.000352	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—PML—Paget's disease of bone	0.000155	0.000347	CbGpPWpGaD
Dasatinib—YES1—Immune System—NUP205—Paget's disease of bone	0.000154	0.000345	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—VCP—Paget's disease of bone	0.000154	0.000345	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.000153	0.000343	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—SQSTM1—Paget's disease of bone	0.000152	0.000341	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.00015	0.000337	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—INPP5D—Paget's disease of bone	0.00015	0.000335	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VCP—Paget's disease of bone	0.000148	0.000332	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000148	0.000332	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—INPP5D—Paget's disease of bone	0.000147	0.00033	CbGpPWpGaD
Dasatinib—BLK—Immune System—SQSTM1—Paget's disease of bone	0.000146	0.000328	CbGpPWpGaD
Dasatinib—FGR—Immune System—SQSTM1—Paget's disease of bone	0.000146	0.000327	CbGpPWpGaD
Dasatinib—HCK—Disease—CALCA—Paget's disease of bone	0.000145	0.000324	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—VCP—Paget's disease of bone	0.000142	0.000317	CbGpPWpGaD
Dasatinib—KIT—Immune System—NUP205—Paget's disease of bone	0.000137	0.000308	CbGpPWpGaD
Dasatinib—FYN—Disease—VCP—Paget's disease of bone	0.000137	0.000306	CbGpPWpGaD
Dasatinib—YES1—Immune System—PML—Paget's disease of bone	0.000136	0.000305	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000136	0.000305	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—INPP5D—Paget's disease of bone	0.000135	0.000304	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—SQSTM1—Paget's disease of bone	0.000134	0.0003	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000132	0.000296	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—CALCA—Paget's disease of bone	0.000132	0.000296	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000132	0.000295	CbGpPWpGaD
Dasatinib—YES1—Immune System—INPP5D—Paget's disease of bone	0.000131	0.000294	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VCP—Paget's disease of bone	0.00013	0.000292	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—NUP205—Paget's disease of bone	0.00013	0.000292	CbGpPWpGaD
Dasatinib—JAK2—Disease—VCP—Paget's disease of bone	0.00013	0.000291	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—CALCA—Paget's disease of bone	0.000128	0.000287	CbGpPWpGaD
Dasatinib—KIT—Disease—NUP205—Paget's disease of bone	0.000127	0.000284	CbGpPWpGaD
Dasatinib—KIT—Immune System—PML—Paget's disease of bone	0.000122	0.000272	CbGpPWpGaD
Dasatinib—ERBB3—Disease—CALCA—Paget's disease of bone	0.00012	0.000269	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NUP205—Paget's disease of bone	0.00012	0.000269	CbGpPWpGaD
Dasatinib—YES1—Immune System—SQSTM1—Paget's disease of bone	0.000118	0.000264	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NUP205—Paget's disease of bone	0.000117	0.000263	CbGpPWpGaD
Dasatinib—KIT—Immune System—INPP5D—Paget's disease of bone	0.000117	0.000263	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000117	0.000262	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VCP—Paget's disease of bone	0.000116	0.000261	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—PML—Paget's disease of bone	0.000115	0.000258	CbGpPWpGaD
Dasatinib—LYN—Immune System—NUP205—Paget's disease of bone	0.000115	0.000257	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NUP205—Paget's disease of bone	0.000114	0.000256	CbGpPWpGaD
Dasatinib—LCK—Disease—VCP—Paget's disease of bone	0.000114	0.000255	CbGpPWpGaD
Dasatinib—FYN—Immune System—NUP205—Paget's disease of bone	0.000113	0.000253	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	0.000111	0.000249	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	0.00011	0.000247	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NUP205—Paget's disease of bone	0.000109	0.000244	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NUP205—Paget's disease of bone	0.000108	0.000243	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—NUP205—Paget's disease of bone	0.000108	0.000242	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NUP205—Paget's disease of bone	0.000107	0.000241	CbGpPWpGaD
Dasatinib—KIT—Immune System—SQSTM1—Paget's disease of bone	0.000105	0.000235	CbGpPWpGaD
Dasatinib—FYN—Disease—NUP205—Paget's disease of bone	0.000104	0.000234	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—PML—Paget's disease of bone	0.000104	0.000232	CbGpPWpGaD
Dasatinib—LYN—Immune System—PML—Paget's disease of bone	0.000101	0.000227	CbGpPWpGaD
Dasatinib—ABL1—Immune System—PML—Paget's disease of bone	0.000101	0.000226	CbGpPWpGaD
Dasatinib—SRC—Disease—VCP—Paget's disease of bone	0.000101	0.000225	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	0.0001	0.000224	CbGpPWpGaD
Dasatinib—FYN—Immune System—PML—Paget's disease of bone	9.99e-05	0.000224	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	9.95e-05	0.000223	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	9.92e-05	0.000222	CbGpPWpGaD
Dasatinib—JAK2—Disease—NUP205—Paget's disease of bone	9.92e-05	0.000222	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—SQSTM1—Paget's disease of bone	9.83e-05	0.00022	CbGpPWpGaD
Dasatinib—LYN—Immune System—INPP5D—Paget's disease of bone	9.79e-05	0.000219	CbGpPWpGaD
Dasatinib—ABL1—Immune System—INPP5D—Paget's disease of bone	9.74e-05	0.000218	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VCP—Paget's disease of bone	9.71e-05	0.000218	CbGpPWpGaD
Dasatinib—FYN—Immune System—INPP5D—Paget's disease of bone	9.64e-05	0.000216	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—PML—Paget's disease of bone	9.62e-05	0.000216	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CALCA—Paget's disease of bone	9.61e-05	0.000215	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VCP—Paget's disease of bone	9.56e-05	0.000214	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CALCA—Paget's disease of bone	9.55e-05	0.000214	CbGpPWpGaD
Dasatinib—JAK2—Immune System—PML—Paget's disease of bone	9.49e-05	0.000213	CbGpPWpGaD
Dasatinib—KIT—Disease—CALCA—Paget's disease of bone	9.42e-05	0.000211	CbGpPWpGaD
Dasatinib—LCK—Immune System—NUP205—Paget's disease of bone	9.41e-05	0.000211	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—INPP5D—Paget's disease of bone	9.28e-05	0.000208	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VCP—Paget's disease of bone	9.21e-05	0.000206	CbGpPWpGaD
Dasatinib—JAK2—Immune System—INPP5D—Paget's disease of bone	9.16e-05	0.000205	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	9.13e-05	0.000205	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VCP—Paget's disease of bone	9.09e-05	0.000204	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—SQSTM1—Paget's disease of bone	8.99e-05	0.000201	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	8.96e-05	0.000201	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CALCA—Paget's disease of bone	8.92e-05	0.0002	CbGpPWpGaD
Dasatinib—LYN—Immune System—SQSTM1—Paget's disease of bone	8.77e-05	0.000197	CbGpPWpGaD
Dasatinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	8.73e-05	0.000196	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CALCA—Paget's disease of bone	8.73e-05	0.000196	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CALCA—Paget's disease of bone	8.73e-05	0.000196	CbGpPWpGaD
Dasatinib—LCK—Disease—NUP205—Paget's disease of bone	8.69e-05	0.000195	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SQSTM1—Paget's disease of bone	8.67e-05	0.000194	CbGpPWpGaD
Dasatinib—FYN—Immune System—SQSTM1—Paget's disease of bone	8.64e-05	0.000194	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CALCA—Paget's disease of bone	8.42e-05	0.000189	CbGpPWpGaD
Dasatinib—SRC—Immune System—NUP205—Paget's disease of bone	8.33e-05	0.000187	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—SQSTM1—Paget's disease of bone	8.32e-05	0.000186	CbGpPWpGaD
Dasatinib—LCK—Immune System—PML—Paget's disease of bone	8.32e-05	0.000186	CbGpPWpGaD
Dasatinib—JAK2—Immune System—SQSTM1—Paget's disease of bone	8.21e-05	0.000184	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	8.13e-05	0.000182	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CALCA—Paget's disease of bone	8.03e-05	0.00018	CbGpPWpGaD
Dasatinib—LCK—Immune System—INPP5D—Paget's disease of bone	8.02e-05	0.00018	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	7.96e-05	0.000178	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NUP205—Paget's disease of bone	7.75e-05	0.000174	CbGpPWpGaD
Dasatinib—FYN—Disease—CALCA—Paget's disease of bone	7.74e-05	0.000174	CbGpPWpGaD
Dasatinib—SRC—Disease—NUP205—Paget's disease of bone	7.69e-05	0.000172	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SQSTM1—Paget's disease of bone	7.61e-05	0.00017	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CALCA—Paget's disease of bone	7.39e-05	0.000166	CbGpPWpGaD
Dasatinib—JAK2—Disease—CALCA—Paget's disease of bone	7.36e-05	0.000165	CbGpPWpGaD
Dasatinib—SRC—Immune System—PML—Paget's disease of bone	7.36e-05	0.000165	CbGpPWpGaD
Dasatinib—LCK—Immune System—SQSTM1—Paget's disease of bone	7.19e-05	0.000161	CbGpPWpGaD
Dasatinib—SRC—Immune System—INPP5D—Paget's disease of bone	7.1e-05	0.000159	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NUP205—Paget's disease of bone	7.05e-05	0.000158	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VCP—Paget's disease of bone	7.05e-05	0.000158	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	6.79e-05	0.000152	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—INPP5D—Paget's disease of bone	6.61e-05	0.000148	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	6.6e-05	0.000148	CbGpPWpGaD
Dasatinib—LCK—Disease—CALCA—Paget's disease of bone	6.45e-05	0.000144	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	6.43e-05	0.000144	CbGpPWpGaD
Dasatinib—SRC—Immune System—SQSTM1—Paget's disease of bone	6.37e-05	0.000143	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	6.25e-05	0.00014	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	6.01e-05	0.000135	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	5.82e-05	0.000131	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	5.79e-05	0.00013	CbGpPWpGaD
Dasatinib—SRC—Disease—CALCA—Paget's disease of bone	5.71e-05	0.000128	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	5.67e-05	0.000127	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	5.63e-05	0.000126	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SQSTM1—Paget's disease of bone	5.58e-05	0.000125	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	5.51e-05	0.000123	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CALCA—Paget's disease of bone	5.42e-05	0.000122	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SQSTM1—Paget's disease of bone	5.38e-05	0.000121	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SQSTM1—Paget's disease of bone	5.31e-05	0.000119	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CALCA—Paget's disease of bone	5.22e-05	0.000117	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CALCA—Paget's disease of bone	5.16e-05	0.000116	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NUP205—Paget's disease of bone	5.05e-05	0.000113	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NUP205—Paget's disease of bone	4.77e-05	0.000107	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	4.65e-05	0.000104	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	4.52e-05	0.000101	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INPP5D—Paget's disease of bone	4.31e-05	9.65e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SQSTM1—Paget's disease of bone	4.12e-05	9.22e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INPP5D—Paget's disease of bone	4.07e-05	9.12e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CALCA—Paget's disease of bone	4e-05	8.96e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	3.81e-05	8.54e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	3.25e-05	7.28e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NUP205—Paget's disease of bone	3.04e-05	6.82e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	2.59e-05	5.81e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	2.35e-05	5.26e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	2e-05	4.49e-05	CbGpPWpGaD
